Literature DB >> 10657710

Alterations of arterial function in end-stage renal disease.

G M London1.   

Abstract

Cardiovascular disease is a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Epidemiological and clinical studies have shown that this is most frequently related to damage of large conduit arteries. Macrovascular disease develops rapidly in uremic patients and is responsible for the high incidence of ischemic heart disease, sudden death, peripheral artery diseases, and congestive heart failure. The most frequent causes of these complications are occlusive lesions due to atherosclerosis. Nevertheless, atherosclerosis, a disease characterized by the presence of plaques, represents only one form of structural response to metabolic and hemodynamic alterations which interfere with the process of aging, i.e., arteriosclerosis, characterized by dilation/hypertrophy and stiffening of arteries. The vascular complications in ESRD are ascribed to two different but associated mechanisms, namely atherosclerosis and arteriosclerosis. Whereas the former principally affects the conduit function with ischemic lesions being the most characteristic consequence, the latter primarily disturbs the cushioning function of large arteries. Arteriosclerosis in ESRD patients is characterized by diffuse dilation and hypertrophy of large conduit arteries and stiffening of arterial walls and represents a clinical form of accelerated aging process. The main clinical characteristics of arterial stiffening concern changes in blood pressure with isolated increase in systolic pressure and normal or lower diastolic pressure. The consequences of these alterations are: (1) an increased left ventricular afterload with development of left ventricular hypertrophy and increased myocardial oxygen demand and (2) altered coronary perfusion and subendocardial blood flow distribution. Epidemiological studies have identified arterial remodeling and stiffening as independent predictors of overall and cardiac mortality in ESRD patients. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10657710     DOI: 10.1159/000045557

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients.

Authors:  Halil Yazici; Huseyin Oflaz; Hamdi Pusuroglu; Savas Tepe; Cengiz Dogan; Ali Basci; Vakur Akkaya; Alaattin Yildiz
Journal:  Int Urol Nephrol       Date:  2011-07-05       Impact factor: 2.370

2.  Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients.

Authors:  Paraskevi Tseke; Eirini Grapsa; Kimon Stamatelopoulos; Elisabeth Samouilidou; Athanasios Protogerou; Christos Papamichael; Antonios Laggouranis
Journal:  Int Urol Nephrol       Date:  2006-11-07       Impact factor: 2.370

3.  Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Authors:  Henning Hoch; Johannes Stegbauer; Sebastian A Potthoff; Lutz Hein; Ivo Quack; Lars Christian Rump; Oliver Vonend
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 4.  Echocardiogram screening in pediatric dialysis and transplantation.

Authors:  Amelia K Le Page; Naganandini Nagasundaram; Ari E Horton; Lilian M Johnstone
Journal:  Pediatr Nephrol       Date:  2022-09-17       Impact factor: 3.651

Review 5.  Vascular calcification in end-stage renal disease.

Authors:  Kristen L Jablonski; Michel Chonchol
Journal:  Hemodial Int       Date:  2013-10       Impact factor: 1.812

6.  Experimentally-Induced Metabolic Acidosis Does not Alter Aortic Fatty Streak Formation in High-Cholesterol Fed Rabbits.

Authors:  Majid Khazaei; Mehdi Nematbakhsh
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

7.  Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform.

Authors:  Amélie LeBeouf; Fabrice Mac-Way; Mihai Silviu Utescu; Nadia Chbinou; Pierre Douville; Simon Desmeules; Mohsen Agharazii
Journal:  Nephrol Dial Transplant       Date:  2009-08-04       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.